Represented Tottenham Acquisition I Limited, a Nasdaq-listed company, in its acquisition of Clene Nanomedicine, Inc., a U.S. clinical-stage biopharmaceutical company.
){kind=logo}
It looks like we may have content for your preferred language. Would you like to view this page in English?
